BlossomHill Therapeutics News and Activities

Acquisition, funding and merger involving BlossomHill Therapeutics.

• BlossomHill Therapeutics has just announced a $84 Million fundraising (posted on December 18 2025).

View the org chart displaying its 23 main executives

Most searched biographies at BlossomHill Therapeutics

• Jean Cui, President and Chief Executive Officer
• Bihua Chen, Director
• George Lee, Director

Popular executive movements at BlossomHill Therapeutics

• John Schmid has joined the company as Director  (posted on May 21 2026).
• Sheila Gujrathi has joined the company as Director  (posted on May 21 2026).

Create your alert
to follow the executive moves at BlossomHill Therapeutics.

BlossomHill Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by BlossomHill Therapeutics

Social media about BlossomHill Therapeutics

• BlossomHill Therapeutics on Wikipedia, Google News & Yahoo Finance
• BlossomHill Therapeutics on LinkedIn, X (Twitter) & YouTube